A phase II trial of CI-921 in advanced malignancies
✍ Scribed by Nancy T. Sklarin; Peter H. Wiernik; William R. Grove; Laura Benson; Abraham Mittelman; Jean A. Maroun; James A. Stewart; Francisco Robert; James H. Doroshow; Peter J. Rosen; Jacques Jolivet; John C. Ruckdeschel; Nicholas J. Robert; Enrique Vèlez-Garcìa; Daniel E. Bergsagel; Lawrence C. Panasci; Aletta M. Merwe; Jacques J. Longueville; Jane Leiby; Charles D. Kowal
- Book ID
- 105014330
- Publisher
- Springer US
- Year
- 1992
- Tongue
- English
- Weight
- 330 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In a cooperative study of the Cancer and Acute Leukemia Group B, 27 evaluable patients with advanced malignant lymphomas were treated with 70 mg/m2 of cisdichlorodiammineplatinum(l1) (cis-platinum) once every three weeks. All patients had received extensive prior therapy. Partial remission was obtai